Literature DB >> 26780170

Neuropathological relationship between major depression and dementia: A hypothetical model and review.

Helena Kyunghee Kim1, Paula Villela Nunes2, Katia C Oliveira3, L Trevor Young4, Beny Lafer5.   

Abstract

Major depression (MDD) is a chronic psychiatric condition in which patients often show increasing cognitive impairment with recurring episodes. Neurodegeneration may play an important component in the pathogenesis of MDD associated with cognitive complaints. In agreement with this, patients with MDD show decreased brain volumes in areas implicated in emotional regulation and cognition, neuronal and glial cell death as well as activation of various pathways that can contribute to cell death. Therefore, the aim of this review is to provide an integrative overview of potential contributing factors to neurodegeneration in MDD. Studies have reported increased neuronal and glial cell death in the frontal cortex, amygdala, and hippocampus of patients with MDD. This may be due to decreased neurogenesis from lower levels of brain-derived neurotrophic factor (BDNF), excitotoxicity from increased glutamate signaling, and lower levels of gamma-aminobutyric acid (GABA) signaling. In addition, mitochondrial dysfunction and oxidative stress are found in similar brain areas where evidence of excitotoxicity has been reported. Also, levels of antioxidant enzymes were reported to be increased in patients with MDD. Inflammation may also be a contributing factor, as levels of inflammatory cytokines were reported to be increased in the prefrontal cortex of patients with MDD. While preliminary, studies have also reported neuropathological alterations in patients with MDD. Together, these studies suggest that lower BDNF levels, mitochondrial dysfunction, oxidative stress, inflammation and excitotoxicity may be contributing to neuronal and glial cell death in MDD, leading to decreased brain volume and cognitive dysfunction with multiple recurrent episodes. This highlights the need to identify specific pathways involved in neurodegeneration in MDD, which may elucidate targets that can be treated to ameliorate the effects of disease progression in this disorder.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Major depressive disorder; Neurodegeneration

Mesh:

Year:  2016        PMID: 26780170     DOI: 10.1016/j.pnpbp.2016.01.008

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  25 in total

1.  Gender-Related Hippocampal Proteomics Study from Young Rats After Chronic Unpredicted Mild Stress Exposure.

Authors:  Lin-Na Ning; Teng Zhang; Jiang Chu; Na Qu; Li Lin; Ying-Yan Fang; Yan Shi; Peng Zeng; Er-Li Cai; Xiao-Ming Wang; Qun Wang; You-Ming Lu; Xin-Wen Zhou; Qi Zhang; Qing Tian
Journal:  Mol Neurobiol       Date:  2017-01-07       Impact factor: 5.590

2.  Potential Role of Vitamin D for the Management of Depression and Anxiety.

Authors:  Gleicilaine A S Casseb; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  CNS Drugs       Date:  2019-07       Impact factor: 5.749

3.  Is use of the internet in midlife associated with lower dementia incidence? Results from the English Longitudinal Study of Ageing.

Authors:  Eleonora d'Orsi; Andre Junqueira Xavier; Snorri Bjorn Rafnsson; Andrew Steptoe; Eef Hogervorst; Martin Orrell
Journal:  Aging Ment Health       Date:  2017-08-10       Impact factor: 3.658

4.  Increased levels of TAR DNA-binding protein 43 in the hippocampus of subjects with bipolar disorder: a postmortem study.

Authors:  Camila Nascimento; Paula V Nunes; Helena K Kim; Renata E P Leite; Roberta D Rodriguez; Katia Cristina De Oliveira; Helena P Brentani; Wilson Jacob-Filho; Ricardo Nitrini; Carlos A Pasqualucci; Lea T Grinberg; Claudia K Suemoto; Beny Lafer
Journal:  J Neural Transm (Vienna)       Date:  2021-12-29       Impact factor: 3.850

5.  The C677T variant in MTHFR modulates associations between brain integrity, mood, and cognitive functioning in old age.

Authors:  Florence F Roussotte; Xue Hua; Katherine L Narr; Gary W Small; Paul M Thompson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-04

6.  Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.

Authors:  Elizabeth Scarr; Catriona McLean; Brian Dean
Journal:  J Neural Transm (Vienna)       Date:  2016-09-29       Impact factor: 3.575

Review 7.  A Review on the General Stability of Mood Disorder Diagnoses Along the Lifetime.

Authors:  Diego de la Vega; Ana Piña; Francisco J Peralta; Sam A Kelly; Lucas Giner
Journal:  Curr Psychiatry Rep       Date:  2018-04-02       Impact factor: 5.285

8.  Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior.

Authors:  Tina C Franklin; Eric S Wohleb; Yi Zhang; Manoela Fogaça; Brendan Hare; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2017-07-21       Impact factor: 13.382

9.  Antioxidative-oxidative balance in epilepsy patients on antiepileptic therapy: a prospective case-control study.

Authors:  Selda Keskin Guler; Bilal Aytac; Zahide Esra Durak; Burcu Gokce Cokal; Nalan Gunes; Ilker Durak; Tahir Yoldas
Journal:  Neurol Sci       Date:  2016-02-01       Impact factor: 3.307

10.  Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants.

Authors:  Rui Lopes; José Carlos Alves; Raquel Garcia Rego
Journal:  Case Rep Med       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.